Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1958 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed442    
    Printed23    
    Emailed0    
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1996  |  Volume : 38  |  Issue : 1  |  Page : 47-50

Adverse Effects of Disulfiram and Patient Compliance


1 Psychiatrist, Sundaram Medical Frundation, Madras - 600 040, India
2 Psychiatrist, Vijaya Hospital, Madras - 600 026, India
3 Psychiatrist, 2nd Street, Srinivasapuram, Tiruvanmiyur, Madras - 600 041, India

Correspondence Address:
T N Srinivasan
Psychiatrist, Sundaram Medical Frundation, Madras - 600 040
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21584118

Rights and PermissionsRights and Permissions

Use of Disulfiram under supervision in well-motivated alcoholics is effective in reducing relapse rates. Several adverse effects, some of them life-threatening, have been reported due to the drug. An awareness of the adverse effects is useful to keep a follow up and sustain patient compliance with the drug. This study of 158 out patients on daily oral disulfiram revealed that though many patients report unpleasant effects most of them could not be distinguished from symptoms of alcoholism present before taking disulfiram and hence cannot be considered as adverse effects of the drug. The actual adverse symptoms were also mild and could be easily managed and were infrequent and not the common cause for poor patient compliance. The study suggests that Disulfiram with its low toxicity can be offered to patients without too much reservation.



[PDF]*

        

Print this article         Email this article